• 1. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 4. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 5. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Toluenes

Introduction to A-CYCLOHEXYL-4-METHYL-BENZENEMETHANOL (CAS No. 28047-28-1)

A-CYCLOHEXYL-4-METHYL-BENZENEMETHANOL, identified by its Chemical Abstracts Service (CAS) number 28047-28-1, is a significant compound in the realm of organic chemistry and pharmaceutical research. This molecule, characterized by its cyclohexyl and methyl substituents on a benzene ring, has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. The presence of both aromatic and aliphatic moieties makes it a versatile intermediate, facilitating various synthetic pathways that are crucial for drug development.

The compound belongs to the class of benzyl alcohols, which are widely recognized for their role in synthesizing more complex molecules. Specifically, A-CYCLOHEXYL-4-METHYL-BENZENEMETHANOL serves as a building block in the construction of pharmacophores, which are key structural elements responsible for the biological activity of drugs. Its molecular structure allows for modifications at multiple sites, enabling chemists to tailor its properties for specific applications.

In recent years, there has been a surge in research focused on developing novel therapeutic agents with improved efficacy and reduced side effects. A-CYCLOHEXYL-4-METHYL-BENZENEMETHANOL has emerged as a valuable candidate in this context. Its ability to undergo various chemical reactions, such as oxidation and reduction, makes it a preferred choice for synthesizing derivatives that exhibit promising biological activities. For instance, researchers have explored its potential in developing anti-inflammatory agents, where its structural features contribute to enhanced binding affinity to target proteins.

The pharmaceutical industry has been particularly interested in A-CYCLOHEXYL-4-METHYL-BENZENEMETHANOL due to its role in the synthesis of active pharmaceutical ingredients (APIs). The compound's stability under different conditions and its compatibility with various synthetic protocols make it an ideal candidate for large-scale production. Moreover, advancements in green chemistry have prompted investigations into more sustainable methods for producing this compound, reducing the environmental impact of its synthesis.

One of the most intriguing aspects of A-CYCLOHEXYL-4-METHYL-BENZENEMETHANOL is its utility in the development of chiral compounds. The presence of a stereocenter allows for the creation of enantiomerically pure derivatives, which are often required for optimal pharmacological activity. Researchers have leveraged this property to develop novel drugs that target specific biological pathways with high selectivity. This has opened up new avenues in personalized medicine, where individual patient responses can be better predicted and managed.

Recent studies have also highlighted the role of A-CYCLOHEXYL-4-METHYL-BENZENEMETHANOL in drug delivery systems. Its structural features enable it to be incorporated into various formulations, including liposomes and nanoparticles, which enhance drug solubility and bioavailability. These advancements are particularly relevant in addressing challenges associated with poorly soluble drugs, improving their therapeutic efficacy.

The chemical synthesis of A-CYCLOHEXYL-4-METHYL-BENZENEMETHANOL involves multiple steps that require precise control over reaction conditions. Modern synthetic methodologies have enabled more efficient and scalable production processes. For example, catalytic hydrogenation techniques have been employed to introduce the cyclohexyl group efficiently, minimizing byproduct formation. Such innovations not only improve yield but also reduce costs associated with purification and isolation.

The versatility of A-CYCLOHEXYL-4-METHYLBENZENEMETHANOL extends beyond pharmaceutical applications. It has found utility in materials science, where its aromatic structure contributes to the development of high-performance polymers and coatings. These materials exhibit enhanced durability and chemical resistance, making them suitable for industrial applications requiring robust performance under harsh conditions.

In conclusion,A-CYCLOHEXYL-4-METHYLBENZENEMETHANOL (CAS No. 28047-28-1) is a multifaceted compound with significant implications across multiple domains of chemistry and medicine. Its unique structural features enable diverse applications, from drug development to advanced materials. As research continues to uncover new possibilities, this compound is poised to play an increasingly important role in addressing global challenges in health and technology.

• 945-49-3(cyclohexyl(phenyl)methanol)
• 14248-31-8(Benzenemethanol, 4-methyl-a-(1-methylpropyl)-)
• 3113-96-0(Benzenemethanol, a-cyclohexyl-, (aR)-)
• 3968-86-3(Benzenemethanol, a-(1-methylpropyl)-)
• 87839-87-0(Benzenemethanol, a,a-dicyclohexyl-)
• 106565-24-6(1,3-Propanediol, 1-cyclohexyl-2-methyl-3-phenyl-, (1R*,2S*,3S*)-(±)-)
• 3195-03-7(Benzenemethanol, a-cyclohexyl-, (S)-)
• 4442-82-4(2-cyclohexyl-1-phenylethan-1-ol)
• 73177-67-0(2-Methyl-1-phenyl-1-pentanol)
• 647028-17-9(1,4-Hexanediol, 5-methyl-1-phenyl-, (1R,4S)-rel-)